methylene blue has been researched along with hydroxocobalamin in 21 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (4.76) | 18.7374 |
| 1990's | 1 (4.76) | 18.2507 |
| 2000's | 1 (4.76) | 29.6817 |
| 2010's | 8 (38.10) | 24.3611 |
| 2020's | 10 (47.62) | 2.80 |
| Authors | Studies |
|---|---|
| Michaely, WJ; Schrauzer, GN | 1 |
| Baysal, F; Dikmen, A; Göçmen, C; Singirik, E; Uçar, P | 1 |
| Endo, Y; Kuroki, Y; Masatono, K; Murakami, M; Ohashi, N; Sugimoto, T; Tamura, M; Yoshioka, T | 1 |
| Boettcher, BT; Cronin, DC; Hong, JC; Kim, J; Lauer, KK; Selim, M; Woehlck, HJ; Zimmerman, MA | 1 |
| Jakobsons, JJ; Khatib, D; Tawil, JN; Woehlck, HJ | 1 |
| Boettcher, BT; Feih, JT; Freed, JK; Ghadiali, HY; Kaiser, M; Pagel, PS; Rinka, JRG; Tawil, JN; Woehlck, HJ; Zundel, MT | 1 |
| Armour, S; Ritter, MJ; Smith, BB; Warner, MA | 1 |
| Cobey, FC; Ortoleva, JP | 1 |
| Feih, JT; Rinka, JRG; Zundel, MT | 1 |
| Hwang, NC; Zeng, LA | 1 |
| Bouillaud, F; Cheung, J; Haouzi, P; Judenherc-Haouzi, A; McCann, M; Tubbs, N | 1 |
| Dalia, AA; Ortoleva, J; Shapeton, A; Vanneman, M | 1 |
| Flynn, BC; Kidd, B | 1 |
| Bloom, A; Faisal, H; Gaber, AO | 1 |
| Brockway, E; Canlas, C; Liao, ZW; Walters, C | 1 |
| Aklilu, AM; Avigan, ZM; Brewster, UC | 1 |
| Finamore, M; Peyko, V | 1 |
| Cook, JC; Ghadimi, K; Kram, BL; Kram, SJ; Ohman, KL | 1 |
| Carpenter, JE; Dunkley, CA; Kiernan, EA; Koch, DD; Moran, TP; Morgan, BW; Murray, BP; Rothstein, LS; Salehi, M; Silver, E | 1 |
| Albertson, TE; Chenoweth, JA; Lewis, JC; Morrissey, BM; Pugashetti, JV; Sandrock, CE | 1 |
| Brokmeier, HM; Gerberi, DJ; Mara, KC; Nei, SD; Seelhammer, TG; Wieruszewski, PM; Wittwer, ED | 1 |
4 review(s) available for methylene blue and hydroxocobalamin
| Article | Year |
|---|---|
Vasoplegia During Cardiopulmonary Bypass: Current Literature and Rescue Therapy Options.
Topics: Cardiopulmonary Bypass; Humans; Hydroxocobalamin; Methylene Blue; Norepinephrine; Vasoplegia | 2020 |
A unique case of purple urine: A case report and literature review.
Topics: Cardiopulmonary Bypass; Humans; Hydroxocobalamin; Male; Methylene Blue; Middle Aged; Pigmentation; Urine; Vasoplegia | 2021 |
The pharmacotherapeutic options in patients with catecholamine-resistant vasodilatory shock.
Topics: Angiotensin II; Ascorbic Acid; Cardiotonic Agents; Catecholamines; Cytomegalovirus Infections; Dobutamine; Humans; Hydroxocobalamin; Methylene Blue; Milrinone; Shock; Shock, Septic; Thiamine; Vasoconstrictor Agents; Vasopressins | 2022 |
Hydroxocobalamin for Vasodilatory Hypotension in Shock: A Systematic Review With Meta-Analysis for Comparison to Methylene Blue.
Topics: Adult; Humans; Hydroxocobalamin; Hypotension; Methylene Blue; Shock; Vasodilation; Vasoplegia | 2023 |
17 other study(ies) available for methylene blue and hydroxocobalamin
| Article | Year |
|---|---|
[Methylene blue as an inhibitor of the reduction of hydroxocobalamin by carbon monoxide].
Topics: Carbon Monoxide; Catalysis; Chemical Phenomena; Chemistry; Hydroxocobalamin; Methylene Blue; Oxidation-Reduction; Vitamin B 12 | 1972 |
An in vitro study of nonadrenergic-noncholinergic activity on the cavernous tissue of mouse.
Topics: Acetylcholine; Adrenergic Agents; Adrenergic alpha-Agonists; Animals; Antidotes; Arginine; Cyclooxygenase Inhibitors; Electric Stimulation; Electrophysiology; Enzyme Inhibitors; Guanethidine; Hematinics; Hydroquinones; Hydroxocobalamin; Indomethacin; Male; Methylene Blue; Mice; Mice, Inbred Strains; Mutagens; Nitroarginine; Penile Erection; Penis; Phenylephrine; Sodium Nitrite; Tetrodotoxin | 1997 |
[Non-approved antidotes in Japan--Foreign antidotes imported for poisoning countermeasures at the Summit 2000].
Topics: Antidotes; Chemical Warfare Agents; Drug Approval; Emergency Medical Services; Ferrocyanides; Fomepizole; Humans; Hydroxocobalamin; Japan; Legislation, Drug; Methylene Blue; Poison Control Centers; Pyrazoles | 2001 |
Hydroxocobalamin for Vasoplegic Syndrome in Liver Transplantation: Restoration of Blood Pressure Without Vasospasm.
Topics: Blood Pressure; Female; Humans; Hydroxocobalamin; Liver Transplantation; Methylene Blue; Middle Aged; Peripheral Arterial Disease; Treatment Outcome; Vascular Resistance; Vasoplegia | 2016 |
Rainbow after the storm.
Topics: Aged; Female; Fluid Therapy; Hematinics; Humans; Hydroxocobalamin; Mediastinitis; Methylene Blue; Resuscitation; Sepsis; Vasoplegia | 2017 |
Hydroxocobalamin With or Without Methylene Blue May Improve Fluid Balance in Critically Ill Patients With Vasoplegic Syndrome After Cardiac Surgery: A Report of Two Cases.
Topics: Adult; Cardiac Surgical Procedures; Critical Illness; Humans; Hydroxocobalamin; Male; Methylene Blue; Vasoplegia; Water-Electrolyte Balance | 2018 |
Cardiopulmonary Bypass Ultrafiltrate Discoloration After Hydroxocobalamin Administration.
Topics: Adult; Blood Loss, Surgical; Cardiopulmonary Bypass; Color; Diagnosis, Differential; End Stage Liver Disease; Enzyme Inhibitors; Heart Valve Diseases; Heart Valve Prosthesis Implantation; Humans; Hydroxocobalamin; Male; Methylene Blue; Nitric Oxide Synthase; Pharmaceutical Solutions; Postoperative Complications; Ultrafiltration; Vasoconstrictor Agents; Vasoplegia | 2019 |
A Systematic Approach to the Treatment of Vasoplegia Based on Recent Advances in Pharmacotherapy.
Topics: Algorithms; Humans; Hydroxocobalamin; Methylene Blue; Risk Factors; Vasoconstrictor Agents; Vasoplegia | 2019 |
Methylene Blue Monotherapy Compared With Combination Therapy With Hydroxocobalamin for the Treatment of Refractory Vasoplegic Syndrome: ARetrospective Cohort Study.
Topics: Aged; Aged, 80 and over; Cohort Studies; Drug Therapy, Combination; Enzyme Inhibitors; Female; Humans; Hydroxocobalamin; Male; Methylene Blue; Middle Aged; Retrospective Studies; Treatment Outcome; Vasoconstrictor Agents; Vasoplegia; Vitamin B Complex | 2019 |
Vasoplegia: More Magic Bullets?
Topics: Cohort Studies; Combined Modality Therapy; Humans; Hydroxocobalamin; Methylene Blue; Vasoplegia | 2019 |
Antidotal Effects of the Phenothiazine Chromophore Methylene Blue Following Cyanide Intoxication.
Topics: Animals; Antidotes; Coma; Cyanides; Cytochromes c; Hemoglobins; Hydroxocobalamin; Male; Methemoglobin; Methylene Blue; NAD; Rats | 2019 |
Repurposing in 2020: Teaching Old Drugs New Tricks.
Topics: Drug Repositioning; Humans; Hydroxocobalamin; Methylene Blue; Pharmaceutical Preparations; Retrospective Studies; Vasoplegia | 2020 |
Unexplained Methemoglobinemia in Coronavirus Disease 2019: A Case Report.
Topics: Acute Kidney Injury; Aged; Antibodies, Monoclonal, Humanized; Antioxidants; Ascorbic Acid; Betacoronavirus; Coronavirus Infections; Corynebacterium; Corynebacterium Infections; COVID-19; Cytokine Release Syndrome; Enzyme Inhibitors; Erythrocyte Transfusion; Hematinics; Humans; Hydroxocobalamin; Hydroxychloroquine; Hypoxia; Male; Methemoglobinemia; Methylene Blue; Pandemics; Pneumonia, Bacterial; Pneumonia, Viral; Renal Replacement Therapy; Respiratory Insufficiency; SARS-CoV-2; Shock, Septic | 2020 |
Hydroxocobalamin for the treatment of refractory intraoperative vasoplegia in a patient with history of squamous cell carcinoma and radiation.
Topics: Carcinoma, Squamous Cell; Cardiopulmonary Bypass; Humans; Hydroxocobalamin; Methylene Blue; Vasoplegia | 2021 |
Use of Intravenous Hydroxocobalamin without Methylene Blue for Refractory Vasoplegic Syndrome After Cardiopulmonary Bypass.
Topics: Cardiopulmonary Bypass; Humans; Hydroxocobalamin; Hypotension; Methylene Blue; Vasoplegia | 2021 |
Hydroxocobalamin or Methylene Blue for Vasoplegic Syndrome in Adult Cardiothoracic Surgery.
Topics: Adult; Cardiopulmonary Bypass; Cohort Studies; Humans; Hydroxocobalamin; Methylene Blue; Retrospective Studies; Vasoplegia | 2022 |
Elevated methemoglobin levels in patients treated with hydroxocobalamin: a case series and
Topics: Adult; Antidotes; Carboxyhemoglobin; Cyanides; Female; Humans; Hydroxocobalamin; Male; Methemoglobin; Methemoglobinemia; Methylene Blue; Middle Aged; Oxygen; Retrospective Studies; Saline Solution; Smoke | 2022 |